Skip to main content
. 2020 Feb 12;2020:7156574. doi: 10.1155/2020/7156574

Figure 1.

Figure 1

Definition of primary and secondary AI resistance in cases of AI as adjuvant therapy (a) and AI for metastatic breast cancer (b).